Discover
AGMB
AgomAb Therapeutics NV
12.17
2 x 8.64
2 x 15.69
bid
ask
+
0.09
0.75%
2 @ 07:30 PM
12.17 +0.00 (0.00%)
| Ytd | -16.93% | |
| 1y | -16.93% |
11.63
day range
12.99
9.61
52 week range
17.82
| Open | 12.26 | Prev Close | 12.08 | Low | 11.63 | High | 12.99 | Mkt Cap | 599.35M |
| Vol | 250.67K | Avg Vol | 125.09K | EPS | -1.56 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 13.29 | 200-d Avg | 12.67 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 48.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 221.59M | ||
| Cash and Equivalents (USD) | 252.91M | ||
| Investments | 30.40M | ||
| Investments Current | 30.39M | ||
| Investments Non-Current | 13.00K | ||
| Current Assets | 258.48M | ||
| Property, Plant & Equipment Net | 1.41M | ||
| Total Assets | 290.92M | ||
| Debt Current | 229.00K | ||
| Total Debt | 1.14M | ||
| Current Liabilities | 20.07M | ||
| Debt Non-Current | 910.00K | ||
| Total Liabilities | 25.55M | ||
| Accumulated Retained Earnings (Deficit) | -212.62M | ||
| Shareholders Equity | 265.38M | ||
| Shareholders Equity (USD) | 302.88M | ||
| Assets Non-Current | 32.44M | ||
| Total Debt (USD) | 1.30M | ||
| Deferred Revenue | 2.39M | ||
| Goodwill and Intangible Assets | 28.72M | ||
| Liabilities Non-Current | 5.48M | ||
| Trade and Non-Trade Payables | 11.84M | ||